SBS-IF is the second orphan disease target indication for Jaguar’s intestinal failure program, which includes microvillus inclusion disease (MVID) – for which the company completed a meeting in ...

The Accepted Abstract Provides Supportive Evidence for the TAMP™ Therapy Platform’s Novel, Localized Approach to Targeted Chemotherapeutic Delivery via Additional Pharmacokinetic and Pharmacodynamic D ...

The next wave of cloud evolution will center on converged data security platforms—architectures that unify policy enforcement ...

EFLM recognizes Babson Diagnostics for innovations in sample collection and preparation ...

Mid-Atlantic Permanente Medical Group shows how trusted data and technology can turn value-based care into better outcomes, ...

An analysis for the Ministry of the Interior highlights the reach of US laws. According to it, data stored in the EU is also ...

Michael Pfeffer is CIDO of Stanford Health Care and Associate Dean at the Stanford University School of Medicine, and a ...

("Profusa” or the "Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation ...

Results from SCOPE to date have enabled Scancell to select Immunobody iSCIB1+, administered needle-free intramuscularly, for further development in patients with selected human leukocyte antigen (HLA) ...

Brahmnik Chachra is honored with a 2025 Global Recognition Award for designing reliable large-scale data systems, ...

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...

Researchers from The University of Texas MD Anderson Cancer Center presented promising new data from two ongoing studies of pivekimab sunirine (PVEK), an antibody-drug conjugate targeting CD123, in ...